Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

ATR vs DBVT vs ALKS vs SLGN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ATR
AptarGroup, Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$8.05B
5Y Perf.+12.3%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
SLGN
Silgan Holdings Inc.

Packaging & Containers

Consumer CyclicalNYSE • US
Market Cap$4.25B
5Y Perf.+20.4%

ATR vs DBVT vs ALKS vs SLGN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ATR logoATR
DBVT logoDBVT
ALKS logoALKS
SLGN logoSLGN
IndustryMedical - Instruments & SuppliesBiotechnologyBiotechnologyPackaging & Containers
Market Cap$8.05B$1712.35T$5.90B$4.25B
Revenue (TTM)$3.87B$0.00$1.56B$6.58B
Net Income (TTM)$387M$-168M$153M$283M
Gross Margin21.9%65.4%17.4%
Operating Margin13.0%12.3%9.8%
Forward P/E22.5x24.8x10.6x
Total Debt$1.53B$22M$70M$4.62B
Cash & Equiv.$402M$194M$1.12B$1.08B

ATR vs DBVT vs ALKS vs SLGNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ATR
DBVT
ALKS
SLGN
StockMay 20May 26Return
AptarGroup, Inc. (ATR)100112.3+12.3%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
Silgan Holdings Inc. (SLGN)100120.4+20.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ATR vs DBVT vs ALKS vs SLGN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ATR and SLGN are tied at the top with 3 categories each — the right choice depends on your priorities. Silgan Holdings Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. DBVT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ATR
AptarGroup, Inc.
The Growth Play

ATR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 5.4%, EPS growth 6.3%, 3Y rev CAGR 4.4%
  • 83.3% 10Y total return vs SLGN's 80.8%
  • Lower volatility, beta 0.66, Low D/E 56.4%, current ratio 1.62x
  • Beta 0.66, yield 1.4%, current ratio 1.62x
Best for: growth exposure and long-term compounding
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.4% vs SLGN's -23.7%
Best for: momentum
ALKS
Alkermes plc
The Quality Angle

ALKS lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
SLGN
Silgan Holdings Inc.
The Income Pick

SLGN is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 21 yrs, beta 0.66, yield 2.0%
  • 10.7% revenue growth vs DBVT's -100.0%
  • Lower P/E (10.6x vs 24.8x)
  • 2.0% yield, 21-year raise streak, vs ATR's 1.4%, (2 stocks pay no dividend)
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthSLGN logoSLGN10.7% revenue growth vs DBVT's -100.0%
ValueSLGN logoSLGNLower P/E (10.6x vs 24.8x)
Quality / MarginsATR logoATR10.0% margin vs DBVT's 0.3%
Stability / SafetyATR logoATRBeta 0.66 vs DBVT's 1.26
DividendsSLGN logoSLGN2.0% yield, 21-year raise streak, vs ATR's 1.4%, (2 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+110.4% vs SLGN's -23.7%
Efficiency (ROA)ATR logoATR7.6% ROA vs DBVT's -89.0%

ATR vs DBVT vs ALKS vs SLGN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ATRAptarGroup, Inc.
FY 2025
Pharma Segment
57.0%$1.7B
Beauty Segment
43.0%$1.3B
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
SLGNSilgan Holdings Inc.
FY 2025
Metal Containers
48.4%$3.1B
Dispensing and Specialty Closures
41.8%$2.7B
Custom Containers
9.8%$638M

ATR vs DBVT vs ALKS vs SLGN — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGATR

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

SLGN and DBVT operate at a comparable scale, with $6.6B and $0 in trailing revenue. ATR is the more profitable business, keeping 10.0% of every revenue dollar as net income compared to SLGN's 4.3%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricATR logoATRAptarGroup, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSLGN logoSLGNSilgan Holdings I…
RevenueTrailing 12 months$3.9B$0$1.6B$6.6B
EBITDAEarnings before interest/tax$801M-$112M$212M$966M
Net IncomeAfter-tax profit$387M-$168M$153M$283M
Free Cash FlowCash after capex$325M-$151M$392M$307M
Gross MarginGross profit ÷ Revenue+21.9%+65.4%+17.4%
Operating MarginEBIT ÷ Revenue+13.0%+12.3%+9.8%
Net MarginNet income ÷ Revenue+10.0%+9.8%+4.3%
FCF MarginFCF ÷ Revenue+8.4%+25.1%+4.7%
Rev. Growth (YoY)Latest quarter vs prior year+10.8%+28.2%+6.5%
EPS Growth (YoY)Latest quarter vs prior year-4.3%+91.5%-4.1%-6.3%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

SLGN leads this category, winning 4 of 6 comparable metrics.

At 14.9x trailing earnings, SLGN trades at a 40% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, SLGN's 8.0x EV/EBITDA is more attractive than ALKS's 17.3x.

MetricATR logoATRAptarGroup, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSLGN logoSLGNSilgan Holdings I…
Market CapShares × price$8.1B$1712.35T$5.9B$4.3B
Enterprise ValueMkt cap + debt − cash$9.2B$1712.35T$4.9B$7.8B
Trailing P/EPrice ÷ TTM EPS21.28x-0.76x24.76x14.91x
Forward P/EPrice ÷ next-FY EPS est.22.47x10.60x
PEG RatioP/E ÷ EPS growth rate1.65x
EV / EBITDAEnterprise value multiple11.48x17.25x7.97x
Price / SalesMarket cap ÷ Revenue2.13x4.00x0.66x
Price / BookPrice ÷ Book value/share3.08x0.66x3.28x1.89x
Price / FCFMarket cap ÷ FCF26.89x12.28x10.07x
SLGN leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

ATR delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SLGN's 2.03x. On the Piotroski fundamental quality scale (0–9), SLGN scores 8/9 vs DBVT's 4/9, reflecting strong financial health.

MetricATR logoATRAptarGroup, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSLGN logoSLGNSilgan Holdings I…
ROE (TTM)Return on equity+18.6%-130.2%+8.8%+12.5%
ROA (TTM)Return on assets+7.6%-89.0%+5.4%+3.0%
ROICReturn on invested capital+10.7%+18.9%+8.7%
ROCEReturn on capital employed+13.8%-145.7%+14.2%+9.9%
Piotroski ScoreFundamental quality 0–95478
Debt / EquityFinancial leverage0.56x0.13x0.04x2.03x
Net DebtTotal debt minus cash$1.1B-$172M-$1.0B$3.5B
Cash & Equiv.Liquid assets$402M$194M$1.1B$1.1B
Total DebtShort + long-term debt$1.5B$22M$70M$4.6B
Interest CoverageEBIT ÷ Interest expense16.19x-189.82x32.30x3.36x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs SLGN's -23.7%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs SLGN's -3.8% — a key indicator of consistent wealth creation.

MetricATR logoATRAptarGroup, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSLGN logoSLGNSilgan Holdings I…
YTD ReturnYear-to-date+2.9%+4.9%+25.3%-1.9%
1-Year ReturnPast 12 months-16.1%+110.4%+16.5%-23.7%
3-Year ReturnCumulative with dividends+7.4%+19.7%+14.5%-11.1%
5-Year ReturnCumulative with dividends-15.3%-69.1%+60.9%+1.4%
10-Year ReturnCumulative with dividends+83.3%-87.0%-11.0%+80.8%
CAGR (3Y)Annualised 3-year return+2.4%+6.2%+4.6%-3.8%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ATR and ALKS each lead in 1 of 2 comparable metrics.

ATR is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs SLGN's 70.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricATR logoATRAptarGroup, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSLGN logoSLGNSilgan Holdings I…
Beta (5Y)Sensitivity to S&P 5000.66x1.26x1.06x0.66x
52-Week HighHighest price in past year$164.28$26.18$36.60$57.04
52-Week LowLowest price in past year$103.23$7.53$25.17$36.15
% of 52W HighCurrent price vs 52-week peak+76.2%+76.3%+96.7%+70.6%
RSI (14)Momentum oscillator 0–10042.848.160.251.1
Avg Volume (50D)Average daily shares traded473K252K2.3M769K
Evenly matched — ATR and ALKS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ATR and SLGN each lead in 1 of 2 comparable metrics.

Analyst consensus: ATR as "Buy", DBVT as "Buy", ALKS as "Buy", SLGN as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). For income investors, SLGN offers the higher dividend yield at 2.00% vs ATR's 1.45%.

MetricATR logoATRAptarGroup, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcSLGN logoSLGNSilgan Holdings I…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$169.67$46.33$44.00$50.50
# AnalystsCovering analysts18152821
Dividend YieldAnnual dividend ÷ price+1.4%+2.0%
Dividend StreakConsecutive years of raises330021
Dividend / ShareAnnual DPS$1.81$0.80
Buyback YieldShare repurchases ÷ mkt cap+4.5%0.0%+0.5%+1.6%
Evenly matched — ATR and SLGN each lead in 1 of 2 comparable metrics.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SLGN leads in 1 (Valuation Metrics). 2 tied.

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

ATR vs DBVT vs ALKS vs SLGN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ATR or DBVT or ALKS or SLGN a better buy right now?

For growth investors, Silgan Holdings Inc.

(SLGN) is the stronger pick with 10. 7% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Silgan Holdings Inc. (SLGN) offers the better valuation at 14. 9x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate AptarGroup, Inc. (ATR) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ATR or DBVT or ALKS or SLGN?

On trailing P/E, Silgan Holdings Inc.

(SLGN) is the cheapest at 14. 9x versus Alkermes plc at 24. 8x. On forward P/E, Silgan Holdings Inc. is actually cheaper at 10. 6x.

03

Which is the better long-term investment — ATR or DBVT or ALKS or SLGN?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ATR returned +83. 3% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ATR or DBVT or ALKS or SLGN?

By beta (market sensitivity over 5 years), AptarGroup, Inc.

(ATR) is the lower-risk stock at 0. 66β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 90% more volatile than ATR relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 2% for Silgan Holdings Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ATR or DBVT or ALKS or SLGN?

By revenue growth (latest reported year), Silgan Holdings Inc.

(SLGN) is pulling ahead at 10. 7% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: AptarGroup, Inc. grew EPS 6. 3% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ATR or DBVT or ALKS or SLGN?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ATR or DBVT or ALKS or SLGN more undervalued right now?

On forward earnings alone, Silgan Holdings Inc.

(SLGN) trades at 10. 6x forward P/E versus 22. 5x for AptarGroup, Inc. — 11. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — ATR or DBVT or ALKS or SLGN?

In this comparison, SLGN (2.

0% yield), ATR (1. 4% yield) pay a dividend. DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is ATR or DBVT or ALKS or SLGN better for a retirement portfolio?

For long-horizon retirement investors, AptarGroup, Inc.

(ATR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 66), 1. 4% yield). Both have compounded well over 10 years (ATR: +83. 3%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ATR and DBVT and ALKS and SLGN?

These companies operate in different sectors (ATR (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and SLGN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ATR is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; SLGN is a small-cap deep-value stock. ATR, SLGN pay a dividend while DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ATR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

SLGN

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.7%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.